Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Texte intégral
Documents relatifs
Ravaud reports personal fees and non-financial support from PFIZER, personal fees and non-financial support from BMS, personal fees and non-financial support from Roche,
In order to examine the effect of treatment mo- dality when controlling for prognostic factors on PFS and OS, we carried out a multivariable analysis including treatment modality
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase
Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers:. a French national, multicentre, open-label randomized,
L’accès à ce site Web et l’utilisation de son contenu sont assujettis aux conditions présentées dans le site LISEZ CES CONDITIONS ATTENTIVEMENT AVANT D’UTILISER CE SITE WEB..
/ La version de cette publication peut être l’une des suivantes : la version prépublication de l’auteur, la version acceptée du manuscrit ou la version de l’éditeur. Access
Kempson SA, Lötscher M, Kaissling B, Biber J, Murer H, Levi M (1995) Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules.. Keusch
s1 , Information S1: Inclusion criteria, Information S2: Exclusion criteria, Information S3: De-escalation or discontinuation criteria, Figure S1: Trial design, Figure S2:
